Biotech firm pitches world-first methane-reducing vaccine

The company was established by AgriZeroNZ, with the New Zealand Greenhouse Gas Research Centre and the New Zealand government.

Lucidome Bio has invented a vaccine aimed to trigger an animal’s immune system to produce antibodies in saliva that suppress the activity of methane-producing microbes in the rumen.

These microbes are responsible for the majority of methane emitted through livestock burps, a significant contributor to climate change.

Lucidome Bio chairman Bridgit Hawkins says that a vaccine that reduces methane would be transformative for farmers across the globe.

“What we’re developing has the potential to fundamentally shift how livestock emissions are managed – offering farmers a practical, cost-effective tool that doesn’t compromise productivity,” Hawkins says.

“It’s a solution that works with nature, not against it,” she says. “Being recognised on a global stage affirms not just the calibre of New Zealand science but the urgency and relevance of what we’re building.”

“It isn’t innovation for innovation’s sake – it’s a critical lever for climate action in agriculture and we’re proud to be leading from the front.”

Meanwhile, Lucidome Bio chief executive David Aitken says that as a nation globally renowned for agricultural excellence and innovation, it is fitting that New Zealand would be stepping onto the world stage with a breakthrough that could help shape the future of farming.

“Lucidome Bio’s selection as a global finalist is more than a recognition of scientific achievement; it’s a signal that New Zealand is leading the charge in practical climate solutions for agriculture,” Aitken says.

“Lucidome Bio is proud to represent the strength of Kiwi science, the power of partnership, and the potential of a vaccine that could transform farming systems around the globe,” he concludes.